Search
for
Sort by
Research 541–570 of 1000+
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- MiR-199a-3p Regulates the PTPRF/β-Catenin Axis in Hair Follicle Development: Insights into the Pathogenic Mechanism of Alopecia Areata
- A Retrospective Study on Alopecia Areata in Children: Clinical Characteristics and Treatment Choices
- Manifestaciones dermatológicas asociadas a la gravedad de la infección por COVID-19. Estudio observacional transversal retrospectivo de 144 pacientes
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Adipose Tissue–Derived Exosomes as a Novel Therapeutic Approach for Refractory Alopecia Areata: A Report of Two Cases
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- A Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo
- Hair Growth-Promoting Effect of Hydrangea serrata (Thunb.) Ser. Extract and Its Active Component Hydrangenol: In Vitro and In Vivo Study
- Non-Scarring Alopecia in Females: A Comprehensive Review
- Comparative characteristics of the effectiveness of drugs for the treatment of alopecia areata in childhood
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition of Androgen Receptor Signaling
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Skin Biology and Ageing
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome